Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide + Chemo in Advanced NSCLC
NCT01836679Phase 2Completed
- Sponsor
- Akeso, Inc.
- Start
- Apr 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in non-small cell lung cancer (NSCLC), sponsored by Akeso, Inc.. Started Apr 2013; status: completed.
02
Drugs
tucidinostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01836679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01836679.